ImmunityBio (IBRX) Change in Cash (2014 - 2026)
ImmunityBio (IBRX) reported Change in Cash of $117.0 million for Q1 2026, up 241.41% year-over-year from $34.3 million in Q1 2025, and up 316.6% on a QoQ basis from $28.1 million in Q4 2025.
ImmunityBio (IBRX) has 13 years of Change in Cash data on file, last reported at $117.0 million in Q1 2026.
- Quarterly Change in Cash rose 241.41% year-over-year to $117.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.3 million (up 301.21% YoY) and the FY2025 annual result came in at -$54.5 million, up 55.3% from the prior year.
- Change in Cash rose to $117.0 million in Q1 2026 per IBRX's latest filing, from $28.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $134.5 million in Q3 2023 and bottomed at -$144.7 million in Q1 2022.
- The 5-year median for Change in Cash is $480000.0 (2022), against an average of $1.5 million.
- The widest annual swing landed in 2022, when Change in Cash sank 1582.14%; it then jumped 18127.08% in 2023.
- Tracing IBRX's Change in Cash over 5 years: stood at $480000.0 in 2022, then jumped by 18127.08% to $87.5 million in 2023, then tumbled by 63.87% to $31.6 million in 2024, then slipped by 11.13% to $28.1 million in 2025, then soared by 316.6% to $117.0 million in 2026.
- Per Business Quant, the three latest IBRX Change in Cash figures stand at $117.0 million (Q1 2026), $28.1 million (Q4 2025), and -$76.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | 117.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.04 Mn |
| Dec 31, 2025 | 28.09 Mn |
| Sep 30, 2025 | -76.81 Mn |
| Jun 30, 2025 | 77.00 Mn |
| Mar 31, 2025 | -82.77 Mn |
| Dec 31, 2024 | 31.61 Mn |
| Sep 30, 2024 | -18.14 Mn |
| Jun 30, 2024 | -2.93 Mn |
| Mar 31, 2024 | -132.42 Mn |
| Dec 31, 2023 | 87.49 Mn |
| Sep 30, 2023 | 134.47 Mn |
| Jun 30, 2023 | -44.98 Mn |
| Mar 31, 2023 | -16.16 Mn |
| Dec 31, 2022 | 480,000.00 |
| Sep 30, 2022 | 42.26 Mn |
| Jun 30, 2022 | 25.66 Mn |
| Mar 31, 2022 | -144.72 Mn |
| Dec 31, 2021 | 116.58 Mn |
| Sep 30, 2021 | -19.43 Mn |
| Jun 30, 2021 | 39.28 Mn |
| Mar 31, 2021 | 9.76 Mn |
| Dec 31, 2020 | -49.77 Mn |
| Sep 30, 2020 | -30.48 Mn |
| Jun 30, 2020 | 56.51 Mn |
| Mar 31, 2020 | -17.15 Mn |
| Dec 31, 2019 | -20.77 Mn |
| Sep 30, 2019 | 762,000.00 |
| Jun 30, 2019 | -5.95 Mn |
| Mar 31, 2019 | 6.66 Mn |
| Dec 31, 2018 | 1.51 Mn |
| Sep 30, 2018 | -812,000.00 |
| Jun 30, 2018 | 4.93 Mn |
| Mar 31, 2018 | -12.68 Mn |
| Dec 31, 2017 | 2.95 Mn |
| Sep 30, 2017 | -18.12 Mn |
| Jun 30, 2017 | 25.44 Mn |
| Mar 31, 2017 | 5.51 Mn |
| Dec 31, 2016 | -23.32 Mn |
| Sep 30, 2016 | -6.82 Mn |
| Jun 30, 2016 | -25.03 Mn |
| Mar 31, 2016 | -112.66 Mn |
| Dec 31, 2015 | -182.71 Mn |
| Sep 30, 2015 | 238.18 Mn |
| Jun 30, 2015 | 70.58 Mn |
| Mar 31, 2015 | -9.25 Mn |
| Dec 31, 2014 | 55.93 Mn |
| Sep 30, 2014 | -812,000.00 |